The effect of atorvastatin on the expression of OPG mRNA and RANKL mRNA of osteoblasts in vitro
Yongxiang Luo
Abstract
Yongxiang Luo
Abstract
Objective: To observe the effect of atorvastatin on the expression o f osteoprotegerin (OPG) mRNA and Receptor Activator of Nuclear Factor-kB Ligand (RANKL) mRNA of osteoblasts derived from mice bone marrow stromal cells. Methods : Osteoblasts derived from mice femurs bone marrow stromal cells of were culture d without or with 10-6-10-8 Matorvastatin medium in subculture. After 7 days, th e expressions of OPG mRNA and RANKL mRNA were obtained with semi-quantative RT-P CR. Results: Semi-quantative RT-PCR examination revealed OPG mRNA expression in each group after 7 days subculture. Atorvastatin promoted OPG mRNA expression si gnificantly in 10-6 mol/L groups and 10-7 mol/L groups, compared with the contro l group (P 0.05). Atorvastatin inhibited osteoblasts RANKL mRNA expression in a dose-dependent manner, this effect was significantly in 10-6 mol/L group and 1 0-7 mol/L group, compared with the control group (P 0.05). Conclusion: Atorvas tatin promotes bone stromal derived osteoblasts OPG expression, while it inhibit s RANKL expression in the same cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the effect of atorvastatin on the expression o f osteoprotegerin (OPG) mRNA and Receptor Activator of Nuclear Factor-kB Ligand (RANKL) mRNA of osteoblasts derived from mice bone marrow stromal cells. Methods : Osteoblasts derived from mice femurs bone marrow stromal cells of were culture d without or with 10-6-10-8 Matorvastatin medium in subculture. After 7 days, th e expressions of OPG mRNA and RANKL mRNA were obtained with semi-quantative RT-P CR. Results: Semi-quantative RT-PCR examination revealed OPG mRNA expression in each group after 7 days subculture. Atorvastatin promoted OPG mRNA expression si gnificantly in 10-6 mol/L groups and 10-7 mol/L groups, compared with the contro l group (P 0.05). Atorvastatin inhibited osteoblasts RANKL mRNA expression in a dose-dependent manner, this effect was significantly in 10-6 mol/L group and 1 0-7 mol/L group, compared with the control group (P 0.05). Conclusion: Atorvas tatin promotes bone stromal derived osteoblasts OPG expression, while it inhibit s RANKL expression in the same cells.
Key concepts: RANKL, Osteoprotegerin, Messenger RNA, Stromal cell, Chemistry, Internal medicine, Endocrinology, Bone marrow